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Letter from the Division Director
Dear Colleagues:
The Global Disease Detection (GDD) program was established in 2004 to promote global 
health security by building capacity to rapidly detect and contain emerging health threats. 
The program began as a series of individual projects aimed at improving global disease 
detection and response capacity for emerging health threats, later followed by an official 
strategy that built on the establishment of GDD Regional Centers with host countries.  
The sixth year of the program, 2010, marked an important milestone with the establishment 
of the GDD Branch in the Division of Global Disease Detection and Emergency Response, 
within the Centers for Disease Control and Prevention’s (CDC’s) Center for Global Health. 
This new structure presents opportunities for enhanced collaboration with the other 
Branches and Offices in the division, including the Global Disease Detection Operations 
Center, the International Emergency and Refugee Health Branch, the Global Health Security 
Branch, the Health Systems Reconstruction Office, and the Office of Policy, Evaluation,  
and Communication.
In addition, GDD has strong collaborations with other programs (see page 10) throughout 
CDC and critical partnerships within the interagency community.  I am especially 
appreciative of our long-standing collaborations with colleagues in the Field Epidemiology 
Training Program (FETP) and influenza program at CDC, and of the support from the 
Cooperative Threat Reduction programs at both the Department of Defense and the 
Department of State.  These partnerships and collaborations have helped us to maximize 
our public health impact.
In conjunction with the World Health Organization (WHO), host countries, a broad network 
of global partners, and our eight GDD Regional Centers, we have achieved important 
progress towards building global public health capacity in support of the International 
Health Regulations (IHR), as highlighted in this Monitoring and Evaluation report.  
Thank you for your continued interest in GDD. I look forward to the coming year as CDC 
continues to work with global health partners to ensure global health security for our 
citizens by strengthening global capacity for emerging health threats.    
Scott F. Dowell, MD, MPH 
Director, Division of Global Disease Detection and Emergency Response 
Center for Global Health 
Centers for Disease Control and Prevention
Foreword
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Letter from the Global Disease Detection Branch Chief
Dear Colleagues:
I am pleased at the progress that has been made to date towards global public health 
capacity for emerging health threats, as well as reminded of the challenges and work that 
remain ahead.   
In 2010, the GDD program helped coordinate a CDC response to several high-profile 
and important outbreaks including cholera in Haiti (see page 13), Nodding Syndrome 
in Uganda (see page 17), and lead poisoning in Nigeria. These outbreaks showed us 
that emerging health threats remain a complicated reality, yet they also highlight the 
value of our robust network of partners, which is essential for rapidly responding to 
outbreaks. Several examples of the contributions and partnerships of the GDD program are 
highlighted throughout this report.
Recognizing the ongoing vulnerability to new disease threats from regions with limited 
detection and response capacity, Congress appropriated funding for an additional GDD 
Regional Center in 2010. South Africa was selected as the eighth GDD Regional Center 
after a competitive selection process (see page 8). The selection of this additional Regional 
Center represents an important step forward in achieving the long-term goal of improving 
global public health security through the establishment of 18 GDD Regional Centers. 
It also reduces geographic vulnerabilities and further strengthens global public health 
capacity-building activities, particularly on the continent of Africa. CDC is working with its 
counterparts in South Africa to establish the Regional Center and to begin initial activities 
as part of this collaboration.  
As a WHO Collaborating Center for Implementation of the IHR, and through ongoing work 
with our network of partners, CDC is contributing to the development of priorities and 
goals for IHR implementation. In addition, in coordination with WHO, U.S. government 
partners, and others, GDD is strategically placing scientific expertise and resources in each 
of the WHO regions to build and strengthen national core capacities for surveillance and 
response in host countries and throughout the region.  
This GDD 2010 Monitoring and Evaluation Report highlights the collective achievements 
of the GDD Regional Centers, other CDC programs, and partners in building global public 
health capacity for emerging health threats. We hope you will enjoy reading and learning 
about these activities and accomplishments.
Frederick J. Angulo, DVM, PhD 
Chief, Global Disease Detection Branch 
Division of Global Disease Detection and Emergency Response 
Center for Global Health 
Centers for Disease Control and Prevention
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Global Disease Detection Program
Global Disease Detection Program
GDD is CDC’s principal and most visible program for strengthening global health security and developing public 
health capacity to rapidly identify and contain disease threats around the world. The program is comprised of 
field-based and CDC headquarters-based components.
GDD Regional Centers
A central focus of GDD is establishing and expanding GDD Regional Centers that build broad-based public 
health capacity in support of the IHR. CDC currently operates eight GDD Regional Centers (see map on page 7) 
at varying levels of capacity (see table below). GDD Regional Centers work with the host country and within the 
region to develop the following six core capacities (see the appendix for detailed descriptions):
 y Emerging infectious disease detection and response
 y Training in field epidemiology and laboratory methods
 y Pandemic influenza preparedness and response
 y Zoonotic disease detection and response at the animal-human interface
 y Emergency preparedness and risk communication
 y Laboratory systems strengthening
GDD Regional Center Capacity and Growth Matrix  
GDD strengthens global health security by building capacity to detect and respond to emerging health threats 
and closing existing geographic vulnerabilities through the establishment of strategically placed GDD Regional 
Centers that build public health capacity in six core areas (see table below).
Table: GDD Regional Center Capacity and Growth Matrix
The GDD Regional Center Capacity and Growth Matrix crosswalks the GDD Regional Centers 
with their level of capacity in the six GDD Core Capacities.  Capacities are added based on 
host country priority.  The emergency preparedness and risk communication core capacity 
was formerly the health communication and information technology core capacity.
The GDD Regional Centers in Kenya and Thailand, established in 2004, has comprehensive 
activities with dedicated staff (existing or expected within 12 months) in the emerging infec-
tions, field epidemiology, pandemic influenza preparedness, laboratory systems strength-
ening, and zoonoses core capacities, and has initial activities underway in the emergency 
preparedness and risk communication core capacity.
The GDD Regional Center in China, established in 2006, has comprehensive activities with 
dedicated staff (existing or expected within 12 months) in the emerging infections, field 
epidemiology, pandemic influenza preparedness, and emergency preparedness and risk 
communication core capacities, and has initial activities underway in the laboratory systems 
strengthening core capacity.
The GDD Regional Center in Egypt, established in 2006, has comprehensive activities with 
dedicated staff (existing or expected within 12 months) in the emerging infections, field 
epidemiology, pandemic influenza preparedness, emergency preparedness and risk com-
munication, and laboratory systems strengthening core capacities, and has initial activities 
underway in the zoonoses core capacity.
The GDD Regional Center in Guatemala, established in 2006, has comprehensive activities 
with dedicated staff (existing or expected within 12 months) in the emerging infections, 
field epidemiology, pandemic influenza preparedness, and laboratory systems strengthen-
ing core capacities, and has initial activities underway in the emergency preparedness and 
risk communication core capacity.
The GDD Regional Center in Kazakhstan, established in 2008, has comprehensive activities 
with dedicated staff (existing or expected within 12 months) in the emerging infections, and 
field epidemiology core capacities, and has initial activities underway in the pandemic in-
fluenza preparedness and emergency preparedness and risk communication core capacities.
The GDD Regional Centers in India and South Africa, established in 2009 and 2010 respec-
tively, has comprehensive activities with dedicated staff (existing or expected within 12 
months) in the emerging infections, field epidemiology, and pandemic influenza prepared-
ness core capacities.
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CDC is one of the world’s leading public health agencies and the only U.S. government agency that 
can rapidly access the in-depth scientific expertise required to respond to complex disease outbreaks. 
GDD provides technical support through its Technical Support Corps (TSC), a cadre of scientists based 
at CDC headquarters who are available to provide 24 hours a day, seven days a week direct support to 
GDD Regional Centers and to facilitate aid to the field in prolonged or complex emergencies. In 2010, 
four TSC members were added for a total of 18 TSC members who have a range of expertise in each of 
the GDD core capacities.
GDD Operations Center
The GDD Operations Center is an innovative epidemic intelligence and response operations unit 
located at CDC headquarters. It uses non-traditional surveillance methods to provide early warning 
about international disease threats so that CDC can rapidly respond to protect public health in the 
United States and the global community. The GDD Operations Center includes experts in infectious 
diseases, veterinary medicine, medical microbiology, epidemiology, and information technology. 
In response to requests for outbreak assistance by a country or WHO, the GDD Operations Center 
coordinates expertise from across CDC and manages an outbreak contingency fund to facilitate rapid 
deployment of teams to the field.
World Map of GDD Regional Centers
There are GDD Regional Centers in 
Kenya and Thailand (established in 2004), 
China, Egypt, and Guatemala (established in 2006), 
Kazakhstan (established in 2008), 
India (established in 2009), 
and South Africa (established in 2010).
Each Regional Center has an approximate regional reach dependent upon estab-






















Location of GDD Center
Approximate Operational  
Reach of GDD Center 
(Note: dependent upon  
establishment of agreements 
with neighboring countries)
GDD Broadens Coverage
Selection of South Africa as the  
Newest GDD Regional Center
In February, 2010, GDD began the process of identifying a country to host a new GDD 
Regional Center. CDC experts used selection criteria including public health significance, 
country commitment, established CDC presence, regional reach, and international partner 
presence to identify and assess eight countries that had previously shown interest in 
hosting a GDD Regional Center. In June, after reviewing input from CDC, U.S. Embassies, 
Ministers of Health, and other relevant government health agencies operating in these 
countries, and after site visits to top candidate countries, South Africa was selected as the 
eighth GDD Regional Center. 
Activities at the GDD Regional Center in South Africa are well underway.
 y Funding has been allocated for the Field Epidemiology and Laboratory Training 
Program (FELTP), infectious disease surveillance, and emergency preparedness;
 y South African counterparts at the Ministry of Health and the National Institute for 
Communicable Diseases have identified office and laboratory space and experienced 
leaders to collaboratively develop the programs;
 y An acting GDD Regional Center U.S. co-director has been appointed; and,
 y Recruitment has begun for permanent U.S. and South African co-directors for the 




2010 marked the first full year of operation for the newly established GDD Regional 
Center in India. The formal launch of the Regional Center occurred in November as part 
of President Obama’s state visit to India when the memorandum of understanding was 
signed by both the Indian and U.S. governments. Many activities are already underway.
India Epidemic Intelligence Service 
The GDD Regional Center in India is providing funding and technical support to the 
Indian National Center for Disease Control (NCDC) to establish an India Epidemic 
Intelligence Service (India EIS) program. This intensive two-year, mentored, competency 
and service-based training is modeled after the FELTP. Early training included a scientist 
exchange, sending technical subject matter experts from the United States to India 
to provide instruction to India EIS residents, and bringing residents to state health 
departments in the United States to learn about how state and national surveillance 
systems work together to provide a cohesive national surveillance system. 
Laboratory Methods Training
In March 2010, the Regional Center supported two scientists from NCDC and the National 
Institute of Virology to travel to the United States to participate in a two-week Arbovirus 
Diagnostics and Surveillance Training Program conducted by CDC’s National Center for 
Emerging and Zoonotic Infectious Diseases. Topics included serology (ELISA, Luminex 
microsphere, PRNT) and molecular diagnostics (PCR-based), mosquito testing (specimen 
processing, RNA detection, virus isolation, data management), and ArboNET and 
arbovirus surveillance data management/analysis.
Zoonotic Disease Reservoirs
In June 2010, the Regional Center provided funding and technical support for a three-
week training session at the National Institute of Virology by a four-member team from 
CDC’s Viral Special Pathogens Branch in the National Center for Emerging and Zoonotic 
Infectious Diseases with experience in bat collection, handling, and specimen testing. 
The training focused on trapping and sample collection from two species of bats that 
required cave and forest collection techniques. Laboratory training was also conducted to 
demonstrate methods of pathogen detection by ELISA (serology) and PCR (nucleic acid 
detection). Assays included detection of known zoonotic viruses such as Marburg, Ebola 
(Reston), and Nipah viruses.
The Regional Center is supporting several integrated approaches to surveillance 
for influenza and other severe viral diseases such as hemorrhagic fevers and viral 
encephalitis to correctly identify viruses associated with these infections. Objectives 
of this surveillance include detection and identification of viruses associated with 
hemorrhagic fever and encephalitis syndromes, surveillance for Hantavirus, surveillance 
of slaughterhouses for zoonotic viruses, and investigation of bats as a potential source 
of emerging viral diseases. These systems will provide information about the ecology of 
these viruses and their potential to infect people and lead to emerging diseases.
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Monitoring and Evaluation
GDD Monitoring and Evaluation 
GDD developed a comprehensive monitoring and evaluation (M&E) program in 2006 which has been used 
to measure progress towards building capacity to rapidly detect and contain emerging disease threats. This 
program monitors and evaluates capabilities and progress on a quarterly basis using a framework that includes 
quantitative and qualitative information about five key activities as described below.
 y Outbreak Response: Ensure outbreak 
investigations and responses are timely  
and comprehensive
 y Pathogen Discovery: Advance public health 
knowledge through innovative research into the 
epidemiology and biology of emerging infections 
and identify novel threats before they spread
 y Training: Build capacity and improve the quality  
of epidemiology and laboratory science through 
applied training
 y Surveillance: Strengthen surveillance systems 
capable of detecting, assessing, and monitoring 
the occurrence and public health significance of 
infectious disease threats
 y Networking: Enhance collaboration through 
shared resources and synergy
GDD collaborates closely with Centers and programs 
at CDC (see side bar) to accomplish its mission. This 
collaboration allows GDD to draw upon expertise 
from across the agency. GDD also works closely with 
a variety of in-country partners including Ministries of 
Health, academic institutions, other U.S. government 
programs, and international and non-government 
organizations. These partners contribute funding, 
expertise, and other resources towards GDD projects 
and goals. Therefore, the results of the M&E reflect the 
shared accomplishments of GDD and its partners.
Internal Partners
Center for Global Health
 y Division of Global HIV/AIDS
 y Division of Parasitic Diseases and Malaria
 y Division of Public Health Systems and 
Workforce Development
National Center for Birth Defects  
and Developmental Disabilities 
 y The Division of Birth Defects and 
Developmental Disabilities
National Center for Environmental Health
 y Division of Emergency and Environmental 
Health Services
National Center for Emerging  
and Zoonotic Infectious Diseases
 y Division of Foodborne, Waterborne, and 
Environmental Diseases
 y Division of Global Migration and 
Quarantine
 y Division of Healthcare Quality Promotion
 y Division of High-Consequence Pathogens 
and Pathology
 y Division of Preparedness and Emerging 
Infections
 y Division of Vector-borne Diseases
National Center for HIV/AIDS,  
Viral Hepatitis, STD & TB Prevention
 y Division of TB Elimination
 y Division of Viral Hepatitis
National Center for Immunization  
and Respiratory Diseases
 y Division of Bacterial Diseases
 y Division of Viral Diseases
 y Influenza Division
 y Global Immunization Division
Office of Public Health Preparedness  
and Response
 y Division of Emergency Operations
Summary of GDD Accomplishments: 2010 and Cumulative
This table contains summary statistics for each of the GDD activities for 2010 as well as cumulative statistics 
covering 2006-2010. The shaded boxes reflect fields not applicable to the corresponding statistics.
Table: Summary of GDD Accomplishments: 2010 and Cumulative
Outbreak Response Activity Area:
Total number of outbreak responses: 156 in 2010, 665 cumulative total 2006-2010  
Number of outbreaks in which response time was within 24 hours: 110(71%) in 2010, 390(75%) 
cumulative total 2006-2010.  This indicator was not collected for all years.  The denominator for 
these percentages are based on the number of outbreaks conducted during the years that the 
indicator was collected, and not the total number of outbreaks from 2006-2010.
Number of outbreaks in which epidemiological activities helped identify risk factors to control 
the outbreak: 116(74%) in 2010, 266(51%) cumulative total 2006-2010.  This indicator was not 
collected for all years.  The denominator for these percentages are based on the number of out-
breaks conducted during the years that the indicator was collected, and not the total number 
of outbreaks from 2006-2010.
Number of outbreaks that achieved measurable health impact (saving lives, prevention of 
disease spread, or policy change): 86(55%) in 2010, 257(50%) cumulative total 2006-2010.
Number of outbreaks in which GDD lab support was provided: 122(78%) in 2010, 331(50%) 
cumulative total 2006-2010.
Number of outbreaks in which GDD lab support provided pathogen confirmation: 104(85%) in 
2010, 283(85%) cumulative total 2006-2010.
Number of outbreaks in which communication support was provided: 102(65%) in 2010, 
219(42%) cumulative total 2006-2010.  This indicator was not collected for all years.  The de-
nominator for these percentages are based on the number of outbreaks conducted during the 
years that the indicator was collected, and not the total number of outbreaks from 2006-2010.
Number of responses that included support to other countries: 39(25%) in 2010, 151(23%) 
cumulative total 2006-2010.  This measure also contributes to the networking activity area.
Number of outbreaks that involved CDC headquarters: 27 (17%) in 2010, 113(22%).  This 
measure also contributes to the networking activity area.  This indicator was not collected 
for all years.  The denominator for these percentages are based on the number of outbreaks 
conducted during the years that the indicator was collected, and not the total number of 
outbreaks from 2006-2010.
Number of outbreaks that involved WHO or Global Outbreak Alert and Response Network 
(GOARN) partners: 13(8%) in 2010, 65(13%) cumulative total 2006-2010.    This measure also 
contributes to the networking activity area.
Pathogen Discovery Activity Area:
Total number of new pathogens detected: 5 in 2010, 54 cumulative total 2006-2010.
Number of pathogens new to the region: 3(60%) in 2010, 46(85%) cumulative total 2006-2010.
Number of pathogens new to the world: 2(40%) in 2010, 6(11%) cumulative total 2006-2010.
Number of pathogen-specific tests available in-country: 29 in 2010, 186 cumulative total 2006-
2010.
Training Activity Area:
Total number of participants in short-term public health training: 12,508 in 2010, 49,729 cumu-
lative total 2006-2010.
Number of Field Epidemiology Training Program (FETP) graduates:  67 in 2010, 302 cumulative 
total 2006-2010.
Number of FETP graduates in public health positions within country: 415 in 2010.
Surveillance Activity Area:
Total population of host countries receiving national surveillance technical support: 
2,960,400,000 based on figures from the 2010 World Population Data Sheet retrieved from the 
Population Reference Bureau website, http://www.prb.org/pdf10/10wpds_eng.pdf.
Total population under surveillance for pneumonia: 5,538,000 in 2010
Total population under surveillance for other syndromes: 72,217,166 in 2010
Total number of syndromes under surveillance: 12 in 2010
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Total number of outbreak responses 156 665
Number of outbreaks in which response time was within 24 hours† 110 71% 390 75%
Number of outbreaks in which epidemiological activities help d identify 
risk factors to control the outbreak† 116 74% 266 51%
Number of outbreak responses that achieved measurable health impact 
(saving lives, prevention of disease spread, or policy change) 86 55% 257 50%
Number of outbreak responses in which GDD lab support was provided 122 78% 331 50%
Number of outbreaks in which GDD lab support provided  
pathogen confirmation 104 85% 283 85%
Number of outbreaks in which communication support was provided† 102 65% 219 42%
Number of responses that included support to other countries* 39 25% 151 23%
Number of outbreaks that involved CDC headquarters support*† 27 17% 113 22%
Number of outbreaks that involved WHO or Global Outbreak Alert and 









ry Total number of new pathogens detected 5 54
Number of pathogens new to the region 3 60% 46 85%
Number of pathogens new to the world 2 40% 6 11%





Total number of participants in short-term public health training 12,508 49,729
Number of Field Epidemiology (and Laboratory)  
Training Program (FE(L)TP) graduates 67 302







Total population of host countries receiving  
national surveillance technical support 2,960,400,000
‡
Total population under surveillance for pneumonia 5,538,000
Total population under surveillance for other diseases and syndromes 72,217,166
Total number of other diseases and syndromes under surveillance 12
* Also contributes to “Networking” activity area
† Indicator was not collected for all years.  The denominator for these percentages are based on the number of outbreaks conducted during the years that indicator was 
collected, and not the total number of outbreaks from 2006-2010.
‡ 2010 World Population Data Sheet. Retrieved from Population Reference Bureau website, http://www.prb.org/pdf10/10wpds_eng.pdf

Outbreak Response
CDC Responds to Cholera in Haiti
On October 21, 2010 the Haitian Ministry of Public Health and Population (Haitian MSPP) confirmed an 
outbreak of cholera in Haiti. This was the first appearance of cholera in more than a decade in the Americas 
and in more than a century in Haiti. 
CDC provided comprehensive support to the Haitian MSPP  
to respond to the outbreak.
These efforts resulted in:
Reduced Mortality CDC’s efforts, as part of the broader international response, contributed to a 
significant decrease in the number of deaths from cholera. By the end of 2010, cholera mortality was 
reduced to the international standard of less than 1%. 
Increased Access to Improved Water, Sanitation, and Hygiene Supplies CDC worked with 
partners to provide access to an adequate supply of clean drinking water, chlorine-based products for 
household drinking water treatment, latrines for proper waste disposal, and soap and hand washing 
facilities at key locations such as schools, hospitals, and clinics. 
Messages in Support of Cholera Prevention and Control  CDC helped develop train-the-trainer 
materials and community health worker materials (including translation into French, Creole, and 
Spanish), and distribute them to over 500 medical providers.
Robust Nationwide Surveillance CDC helped establish a national cholera monitoring system which 
allowed Haitian MSPP to identify cases in real-time, pre-position resources, track the evolution of the 
epidemic, and target interventions. 
GDD played a significant role in the larger CDC response efforts,  
ensuring that the response was rapid, comprehensive, and effective.
As part of these efforts, GDD:
Enabled Rapid Response The GDD Operations Center outbreak response contingency fund (see 
pages 7 and 31) supported the initial deployment of 67 public health professionals to provide on-the-
ground support in Haiti until supplemental funding became available.
Leveraged a Global Network Most clinicians in Haiti had never managed cholera before, and initial 
mortality was more than 6%. Drawing on its global network of partners, GDD requested assistance 
from the International Center for Diarrheal Disease Research in Bangladesh (ICDDR,B) where cholera 
is endemic. ICDDR,B assisted CDC and MSPP in conducting a train-the-trainer program in all regions 
in Haiti to instruct healthcare providers on the treatment and management of cholera. Now, the initial 
trainees have become the trainers and continue to share their knowledge. 
Deployed Regional Resources Multidisciplinary rapid response teams trained by the GDD Regional 
Center in Guatemala and regional partners in the wake of pandemic influenza H1N1 2009 (H1N1) were 
rapidly mobilized to provide much needed surge capacity.
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GDD conducts and supports outbreak investigations at the invitation of the Ministry  
of Health by providing technical assistance, human and zoonotic epidemiology  
expertise, laboratory support, and health communication support. In addition, GDD 
Regional Centers can request assistance from scientific experts at CDC headquarters 
when additional technical assistance such as specialized laboratory testing or field  
deployment is needed.
Accomplishments in 2010
GDD Regional Centers assisted in over 156 outbreak investigations and other public 
health emergencies, including typhoid fever and goatpox in China; influenza H5N1 and 
H5N2 in Egypt; respiratory syncytial virus and influenza H3N2 in Guatemala; Congo-
Crimean hemorrhagic fever (see story on page 15) and anthrax in Kazakhstan; dengue 
and Rift Valley fever in Kenya and; typhoid fever and dengue in Thailand.
Outbreak Response
GDD helps build national and regional capacity. In 2010, outbreak responses
Were Timely
 y 71% received a response within 24 hours of the request
Were Comprehensive
 y 78% involved laboratory support, and of these, 85% led to a confirmed cause
 y 65% included health communication support
 y 25% included support to other countries
Achieved Public Health Impact
 y 74% led to identification of risk factors
 y 55% led to saving of lives, preventive action, or policy change
Disease Control in China put to the “Text”
The GDD Regional Center in China and the China Ministry of Health recently explored 
the use of mobile phone text messaging for sharing vital public health information. 
Based on the premise that outbreak control improves when prevention information 
spreads rapidly, the GDD Regional Center worked with the Chinese national public 
health hotline and the Ministry of Health to evaluate the use of SMS text-messages to 
rapidly disseminate health messages. Together, they sent text messages with health 
advice to thousands of mobile phone users. H1N1 messages were used for the first 
large-scale evaluation conducted in 2010 in Shanghai, China’s largest city. The evaluation 
showed that those people receiving H1N1 information via text message gained increased 
knowledge compared with those in a control group. The recipients of the SMS text 
messages also showed an increased change of attitude regarding influenza prevention 
and control measures such as hand hygiene and staying home when sick. Encouraged 
by the Shanghai results, the Ministry of Health has established a permanent health text 
messaging code available in all 31 provinces for emergency messaging as well as for 
routine public health education and promotion.
Cumulative Number of Outbreak Responses
Graph of cumulative number of outbreaks re-







Response to Congo-Crimean Hemorrhagic Fever in 
Kazakhstan
Congo-Crimean hemorrhagic fever (CCHF) causes death for 10% - 50% of 
the people who become infected. CCHF spreads to people through tick 
bites, or contact with infected animal blood. Usually, CCHF does not affect 
its animal hosts, but it can cause serious illness to humans. Symptoms 
range from headache, high fever, and joint pain to vomiting, large areas of 
severe bruising, severe nosebleeds, and other uncontrolled bleeding.  
In recent years, three districts in southern Kazakhstan have reported as 
many as 20 cases per year, which resulted in the Ministry of Health of 
Kazakhstan requesting that the GDD Regional Center in Kazakhstan help 
build capacity to detect and contain the spread of this deadly disease. 
Together with support from the Department of Defense’s Defense Threat 
Reduction Agency and technical experts from CDC, the GDD Regional 
Center is helping develop a comprehensive strategy focused on prevention 
to defeat the deadly virus.
Transmission of CCHF is most common to livestock workers who come 
in contact with infected ticks carried by cattle; some cases, however, 
have occurred in medical personnel exposed to the blood of hospitalized 
patients. Messages in Russian and the Kazakh languages were created 
to teach hospital workers, local public health agencies, and entire 
communities how to avoid and care for tick bites, and how to recognize 
signs of infection. The GDD Regional Center also conducted an intensive 
five-week course to improve local capability to detect the virus that causes 
CCHF and study the epidemiology of CCHF. The result of these combined 
efforts is improved testing to detect CCHF in the laboratory, suggested 
approaches for tick control in livestock, and enhanced prevention measures 
to protect livestock workers and others who come in contact with ticks.


















Coordinated Campaign Against Nodding Syndrome in Uganda
Since the early 1960s, there have been reports of a mysterious disease affecting children in Africa, 
which causes uncontrolled head nodding (particularly in the presence of food), seizure-like 
activity, and in many cases, death. This illness is referred to as “Nodding Syndrome” after its most 
notable symptom. In late 2009, reports from Northern Uganda suggested that over 2,000 children 
were afflicted with this unusual illness. 
In 2010, the GDD Operations Center alerted experts from programs across CDC, including 
infectious diseases, nutrition and physical activity, and birth defects and developmental 
disabilities, to study the outbreak. Through its outbreak response contingency fund, the GDD 
Operations Center supported two field deployments of multidisciplinary teams of scientists to 
the field to investigate. These teams consisted of experts in pediatric infectious disease, pediatric 
neurology, toxicology, laboratory, and geographic information systems.
The teams documented for the first time that Nodding Syndrome is a novel complex epilepsy 
syndrome, and that the head nodding was a direct manifestation of seizures that cause a brief 
lapse in muscle tone due to alterations in brain function. The cases in Northern Uganda are 
clustered in time and space, with rates of disease many times higher than expected background 
rates of complex epilepsy. Children living under the poorest conditions where there is not 
sufficient food, clean water, or adequate housing seem most susceptible to this condition. CDC 
is continuing to investigate the disease further to identify the underlying cause in the hope of 
improving management and eventually curing the illness through effective treatment.
GDD is working to identify pathogens that are new to the region or the world which 
represent unrecognized and potentially important risks. In addition, GDD helps countries 
to establish or significantly improve laboratory testing capacity to confirm emerging 
health threats and implement appropriate response interventions more quickly.
Accomplishments in 2010
GDD Regional Centers:
 y Detected three pathogens that were new to their regions
 y Discovered two new pathogens that are new to the world
 y Built capacity for 29 diagnostic tests
Identifying Diseases in Disguise in Thailand
Emerging diseases may often look and behave like existing diseases by producing 
similar symptoms in infected patients. These diseases may continue to spread 
undetected and unconstrained if current treatment and prevention measures are 
not effective. The GDD Regional Center in Thailand is collaborating with Thailand’s 
Ministry of Public Health and Ministry of Agriculture, the Thailand Red Cross, and U.S. 
CDC to identify new pathogens with clinical presentations similar to known diseases 
and syndromes (such as non-specific fever), and help answer questions about the 
causes and transmission routes of new and distinct infectious diseases. Bartonella and 
other emerging zoonotic pathogens are a specific focus.
Between 2007 and 2010, the Regional Center identified four Bartonella species linked 
to serious previously undiagnosed human diseases that are likely new to Thailand and 
possibly the world. These pathogens are in the process of being characterized using 
genomic methods. This work builds upon the 2007 discovery by the GDD Regional 
Center in Thailand and CDC-Fort Collins of a pathogen that was new to the world, 
Bartonella tamiae, and the first culture-confirmed Bartonella infection in Thailand. 
These ongoing efforts demonstrate the importance of pathogen discovery work to 




GDD Regional Center Pathogen Name New to 
Egypt Crimean Congo hemorrhagic fever variant World
Kenya Bartonella (novel species) World
Thailand Coxiella burnetii Region
Thailand Bartonella henselae Region
Thailand Bartonella bovis Region
Egypt discovered Crimean Congo 
hemorrhagic fever variant that is new 
to the world. 
Kenya discovered a novel species of 
Bartonella that is new to the world.
Thailand detected Coxiella burnetti, 
Bartonella heselae, and Bartonella bo-
vis, all of which are new to the region.
Cumulative Number of New Pathogens  
Detected and Testing Capacity
Graph of cumulative diagnostic testing capac-
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Pathogen Detection in an Egyptian Abattoir
In a pilot study at an Egyptian abattoir, epidemiologists from the  
GDD Regional Center in Egypt discovered a new version of an old 
infectious threat to human health: CCHF, (described on page 15)  
which is commonplace across Africa, the Balkans, the Middle East,  
and parts of Asia. 
The viral variant that was identified indicated the presence of a 
disease with potentially significant human impact, and underscored 
the importance of expanding novel approaches to disease detection 
for public health investigators. This study was unusual, not just for its 
location, but also its scope, which included human, animal, and vector 
surveillance. Staff collected and tested specimens taken from slaughtered 
livestock including cattle, buffalo, camels, and sheep. The staff found the 
previously unknown variant of CCHF in ticks taken from the carcasses of 
three camels originating in Somalia and Sudan. Because of the success 
of this surveillance model, the Regional Center is expanding the pilot 
surveillance activities to a live animal market in the Cairo area. The 
discovery of a new variant of the CCHF virus helps scientists stay ahead 




A Public Health Network Rallies to Eradicate Polio in Central Asia
Vigilance comes with the territory in the global polio eradication effort. In 2002, the European 
Region (which includes Russia and the Central Asia Republics of Kazakhstan, Tajikistan, and 
Turkmenistan) was declared polio-free. But in April 2010, an enormous outbreak of polio was 
detected in Tajikistan, with subsequent exportation of cases to Russia, Turkmenistan, and 
Kazakhstan. By year’s end this outbreak was responsible for more than 50% of all the world’s 
polio cases in 2010. In Tajikistan, there were 457 laboratory-confirmed polio cases and 29 
deaths in a country that had previously not had any cases since 1997. 
The outbreak was immediately addressed through national vaccination campaigns 
coordinated by WHO, with support from CDC’s Global Immunization Division (GID). In 
resource-constrained areas of the world, mounting a rapid, large-scale vaccination campaign 
presents significant challenges. Fortunately, the FETP has been training public health 
professionals in the Central Asian Republics since 2003. The highly-trained graduates of 
this program have remained in the region and frequently hold leadership positions in their 
respective institutions and Ministries of Public Health. Scientists from the GDD Regional 
Center in Kazakhstan were able to work in collaboration with the network of FETP graduates 
to provide expertise and assistance. They monitored surveillance efforts in collaboration 
with GID and other partners, and provided quality assurance during the mass vaccination 
campaigns that dispensed over 15,000,000 doses of vaccine. CDC’s prior investment in 
professional capacity building helped build strong public health alliances that contributed to 
controlling the polio outbreak.
GDD strengthens in-country and regional public health capacity for outbreak detection 
and response through short-term, classroom-based instruction, and more rigorous, in-
depth instruction and training of senior epidemiologists through the FE(L)TP.
Accomplishments in 2010
 y 67 epidemiologists and laboratorians graduated from FE(L)TP at GDD Regional 
Centers (see figure on page 23).
 y 415 FE(L)TP graduates remained in public health positions in country or within the 
region after graduation.
 y More than 12,000 people participated in short-term public health training (see figures 
below). Instruction included a combination of advanced training for core public health 
personnel and more basic training for clinicians and others whose work impacts the 
public health system.
Cumulative Number of Training Participants
Graph of the 
cumulative number 








Number of Participants Trained by Topic, 2010
Total number of participants trained by topic 
in 2010.
Some trainings included more than one topic.
12,508 total participants trained.  
7,108 trained in epidemiology or laboratory 
topics.  
2,133 trained in other topics.  Other topics 
include zoonotic diseases, biotechnology, vac-
cines, ethics, management, resource mobiliza-
tion, procurement, and grants.  
1,134 trained in general or all hazards pre-
paredness.  Other topics includes zoonotic 
diseases, biotechnology, vaccines, ethics, 
management, resource mobilization, procure-
ments, and grants.  
727 trained in health communication and/o     r 
risk communication. 
330 trained in rapid response.  
235 trained in global salmonella surveillance.
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Training
* “Other topics” include zoonotic diseases, biotechnology, vaccines, ethics, management, resource mobilization, procurements, and grants.* 
























Number Trained in Global Salmonella Surveillance
Number Trained in Health Communication
/Risk Communication
Number Trained in Rapid Response
Number Trained in Other Topics*
Number Trained in Epi/Lab
Total Number of Participants Trained
Building Laboratory Capacity in Central America
High quality laboratories are critically important in identifying pathogens 
that have the potential to cause pandemics. In 2010, the influenza program 
at the GDD Regional Center in Guatemala helped the National Influenza 
Centers in Guatemala and Nicaragua improve the quality and reliability of 
their testing, culminating in their formal accreditation as Central American 
National Reference Laboratories. The Regional Center helped identify and 
address the gaps necessary to meet the strict accreditation criteria required 
by PAHO. They provided equipment and training to perform powerful new 
laboratory tests, to analyze, interpret, and report the results, and to ship 
isolates to WHO. 
This effort is an important milestone toward better influenza control  
around the world because accredited labs have trained personnel, 
equipment, and supplies to find and identify new influenza viruses, 
including those with the potential to cause pandemics. The two new 
accredited national laboratories in Guatemala and Nicaragua are now 
recognized as a part of Central America’s network of six regional  
accredited National Influenza Centers.
Cumulative Number of Senior Epidemiologists  
(FE(L)TP)
Chart: Cumulative number of senior 
epidemiologists graduating from the 























Building Surveillance Capacity in Eritrea
Rotavirus is the leading cause of severe diarrhea in infants and young children 
worldwide. Globally, it causes more than a half a million deaths each year 
in children younger than 5 years old. Pediatric bacterial meningitis is also a 
significant health problem in the developing world, particularly in Africa. Prior to 
2010, Eritrea had no rotavirus surveillance and substandard pediatric bacterial 
meningitis surveillance, resulting in many cases going undetected and untreated, 
and leading to further spread of these diseases.
 The GDD Regional Center in Kenya, through its FELTP, partnered with WHO to 
evaluate Eritrea’s pediatric bacterial meningitis surveillance system and to help 
establish a rotavirus diarrheal surveillance system in 2010. With assistance from 
WHO’s Africa Regional Office, Eritrea Ministry of Health, Orotta National Paediatric 
Referral Hospital, and National Reference Laboratory, staff from the GDD Regional 
Center supported laboratory training to establish testing capacity for rotavirus and 
bacterial meningitis. They helped develop laboratory systems to ensure consistent, 
safe, and high quality laboratory support. More than 50 doctors, nurses, data 
managers, epidemiologists, and surveillance officers were trained in their roles 
within the surveillance system. 
Eritrea can now correctly estimate the burden of rotavirus, diarrheal diseases, and 
meningitis, which could be the first step for Eritrea to implement a vaccination 
program to proactively prevent these diseases. This institutional capacity will 
better enable Eritrea to detect and respond to outbreaks more rapidly.
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Surveillance
GDD includes a network of Regional Centers capable of conducting surveillance for emerging 
infectious diseases. GDD Regional Centers use population-based surveillance, linked to powerful 
laboratory diagnostics, to accurately estimate burden of disease and direct control efforts where 
they can be most effective. Surveillance data are used to support evidence-based decision 
making in public health practice and policy.
Accomplishments in 2010
 y 5.5 million persons are under population-based surveillance for pneumonia; and,
 y 72 million persons are under population-based surveillance for other locally important 
diseases and syndromes.
Enhancing Surveillance in Thailand 
A country’s ability to detect diseases is only as good as the information being produced 
by its surveillance system. If there are limited or poor quality data coming into a 
surveillance system, the decisions being made using these data will not be very useful 
or effective. For years, Thailand’s invasive bacterial infections surveillance was hampered 
by a lack of resources and inadequate reporting. In collaboration with CDC, the GDD 
Regional Center in Thailand partnered with the Thailand Ministry of Public Health to 
address these challenges. 
This collaboration has revitalized the existing surveillance system by improving the 
quality of data collection and reporting, and by more actively looking for cases. This 
system was further enhanced by including two provincial population-based surveillance 
sites for bloodstream infections which are managed by scientists from the GDD Regional 
Center. Because the enhanced system integrates laboratory, clinical, and epidemiological 
data, it is now able to effectively monitor trends, detect emerging antimicrobial resistance, 
and assess the impact of prevention and control programs. The addition of the two 
population-based sites also gives the system the power to accurately estimate the 
extent to which a disease exists in the population, to identify high-risk groups, and to 
describe the characteristics of that disease, including what drugs are likely to be most 
effective for treatment. This information helps public health officials to efficiently and 
effectively direct resources and investigations. This system is also flexible and scalable 
so that surveillance for additional pathogens (including non-bacterial pathogens) can be 
conducted quickly, allowing the network to serve as a national resource in public health 
emergencies. The end result is the Thailand Invasive Bacterial Infections Surveillance-
Plus, a network of more than 30 sites that are well positioned to respond to a wide array 
of emerging public health threats.
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Fingerprinting Pathogens in China
The GDD Regional Center in China is tailoring proven approaches from  
the United States to help the Chinese Ministry of Health and other partners 
find the cause of food-borne disease outbreaks. Like fingerprints, disease-
causing pathogens leave their own genetic marks. The GDD Regional Center 
in China is helping establish laboratory techniques that effectively “dust” for 
evidence that can prove whether two ill people, regardless of where they live, 
were sickened by the same pathogen. With this information, epidemiologists 
can narrow their search for the tainted products and protect people from 
further exposures.
Chinese microbiologists and epidemiologists in eight provinces are now 
equipped to receive specimens and identify common foodborne diseases 
as well as entirely new ones. Along with experts in medical epidemiology, 
microbiology, environmental health, and program management, scientists at 
the GDD Regional Center in China are finding more Salmonella cases than 
ever, and have recently discovered a new strain of Salmonella Typhimurium 
that has been causing illness among children. Through enhanced training 
and state-of-the-art laboratories, these public health experts can “fingerprint” 
the genetic markers for pathogens causing food-borne infections and identify 
their source. This essential step makes food safer – whether it’s consumed in 
China, exported to the United States, or shipped worldwide.
Diseases and Syndromes Under  
Population-Based Surveillance at 
GDD Regional Centers in 2010
 y Bacterial blood stream infections
 y Diarrheal disease
 y Febrile illness of unknown origins
 y Fungal blood stream infections
 y Invasive bacterial infection
 y Influenza-like illnesses









Flattening the Learning Curve
Emergencies that are not handled well can quickly become public health crises. Stakeholders 
in emergency preparedness and response must work collaboratively to respond effectively. 
When multiple agencies are involved in the same response but are unaware of each other’s 
activities, duplication of efforts, unrecognized gaps in the response, mismanagement of 
resources, and confusion among responders and the general population may occur. 
GDD provided funding and support for an intensive week-long forum which was managed 
jointly by CDC’s International Emergency and Refugee Health Branch and the WHO Regional 
Office for the Eastern Mediterranean, Center for Health Risk Reduction. This forum, facilitated 
by a group of experienced humanitarian and public health experts from CDC, WHO and the 
United Nations system, was designed to help individuals, organizations, countries, and regions 
working in public health emergencies to increase their capacity to prepare for and respond to 
complex emergencies and disasters. 
This forum brought together the emergency coordinators from the GDD Regional Centers in 
Kenya, Guatemala, China, Thailand, and Kazakhstan, representatives from all six WHO Regional 
Offices, and representatives from other partner organizations that collaborate with CDC on 
emergency preparedness and response. It provided an opportunity for participants to share 
the most up-to-date knowledge, skills, and field experience, and to collaborate to increase 
preparedness locally.
This forum was an important networking opportunity for the GDD Regional Center in Kenya, 
which, as the newest emergency preparedness program of the group, needed to share its 
experiences and learn from other countries. In Kenya, emergency preparedness and response 
was previously fragmented, with many stakeholders working independently in their own 
sectors. Kenyan participants learned how to manage the multiple efforts of ministries and 
agencies working on emergency preparedness, and how to better coordinate plans and 
preparations for future events. This forum strengthened an established network of partners 
and helped the GDD Regional Center in Kenya improve its emergency preparedness  
program more rapidly.
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Rapid detection and response to disease threats anywhere in the world requires a 
strong network with a global reach. GDD builds a global “network of networks” through 
strategically placed GDD Regional Centers linked to their host countries and regional 
partners. Components of GDD, headquartered in Atlanta, play a significant role in linking 
the Regional Centers with other U.S. government agencies, and international organizations 
such as WHO and the Global Outbreak Alert and Response Network (GOARN).
Improving Surveillance Systems in Oman
In the fall of 2007, the GDD Regional Center in Egypt invited Jordan, Oman, and Egypt to 
become part of a Severe Acute Respiratory Infection (SARI) surveillance network. These 
countries did not have the expertise or equipment to diagnose SARI accurately. So the 
GDD Regional Center provided funds and technical assistance to help them establish 
SARI sites in their countries. With assistance to the Ministries of Health in Jordan, Egypt, 
and Oman, and the Ministry of Higher Education in Egypt, the countries quickly gained 
competency to process samples to identify the causes of people hospitalized with 
respiratory infections. 
In partnership with the Ministry of Health and Ministry of Higher Education, the GDD 
Regional Center in Egypt helped increase clinical and diagnostic capability to improve 
their early warning detection surveillance system for SARI-related epidemics, including for 
influenza. The success of the surveillance system during the 2009 H1N1 pandemic led the 
Oman Ministry of Health to adopt the SARI program and fund it as part of the national 
surveillance system in 2010. The success in Oman has made it possible for the Regional 
Center to serve as a regional public health resource to other countries in the region.
Bringing Laboratory Capacity to Refugees in Kenya
Before 2010, laboratory capacity in Dadaab refugee camp was extremely limited, 
involving primarily microscopy and rapid tests. Dadaab refugee camp has a capacity of 
90,000, but it currently hosts over 300,000 refugees. In an overcrowded living situation, 
poor water and sanitation conditions make refugee camps 
susceptible to a wide range of infectious diseases. Due to lack 
of good diagnostic capabilities and efficient transportation 
systems, illnesses were detected late and lives were lost.
In 2010, the GDD Regional Center in Kenya, together with 
CDC’s Division of Global Migration and Quarantine, worked 
with several international organizations, including the United 
Nations Human Rights Council and the International Rescue 
Committee, to help renovate a laboratory in the Dadaab 
refugee camp complex. Renovations included adding the 
capacity to analyze blood and stool cultures, the diagnostic 
tool known as ELISA, and the necessary training for the 
laboratory staff. The expanded and improved laboratory 
benefits the refugees of the camp, the host community of 
Dadaab town, the entire North Eastern Province in Kenya,  
and could be utilized for Southern Somalia as well.
With this laboratory, when a mother brings her child to the hospital, the doctor will be 
able to determine the cause of the child’s illness, such as staphylococcus, streptococcus or 
other epidemic prone diseases such as cholera or shigella. With this diagnostic capacity, 
healthcare workers are able to treat patients more accurately, and, in the event of an 




The GDD Operations Center
Through its surveillance function, the GDD Operations Center in Atlanta is frequently  
the first to alert CDC staff (based in Atlanta and internationally) about a disease outbreak. 
The GDD Operations Center utilizes multiple sources of information about disease 
events, including internet-based media reports which scan for key words in more than 
40 languages. To investigate and confirm the existence of these outbreaks, the GDD 
Operations Center relies on a global network, including CDC subject matter experts 
and their international networks, WHO headquarters and regional offices, and other 
international partners. The GDD Operations Center is also a member of the Biosurveillance 
Indications and Warning Analytic Community, a U.S. government interagency collaboration 
that allows 12 agencies to exchange unclassified information through a secure Web-based 
portal. The GDD Operations Center is also CDC’s liaison with GOARN, receiving and 
responding to requests for international assistance to control disease outbreaks.
In 2010, the GDD Operations Center outbreak response contingency fund supported 17 
outbreak investigations in 14 countries (see table below).
Aflatoxin outbreak response in Kenya.  The GDD Operation Center deployed and funded CDC 
staff, provision of lab supplies.
Anthrax outbreak response in Scotland. The GDD Operations Center deployed and funded CDC 
staff, provision of anti-toxin.
Botulism outbreak response in Thailand. Provided funding for the provision of anti-toxin and 
associated shipping costs.
Cholera outbreak response in Haiti. The GDD Operations Center deployed and funded CDC staff, 
procurement and shipping.
Cholera outbreak response in Dominican Republic. The GDD Operations Center deployed and 
funded CDC staff.
Cholera outbreak response in Cameroon. The GDD Operations Center deployed and funded CDC 
staff, transportation, supplies/equipment, communications.
Cholera outbreak response in Kenya. The GDD Operations Center deployed and funded CDC staff, 
transportation, supplies/equipment, communications.
Earthquake related outbreak response in Haiti.   The GDD Operations Center deployed and 
funded CDC staff, provision of lab supplies.
Fungal outbreak Investigation in Jamaica. The GDD Operations Center deployed and funded CDC 
staff, transportation, supplies/equipment, communications.
Hepatitis E Virus outbreak response in Uganda.  The GDD Operations Center deployed and fund-
ed CDC staff, transportation, supplies/equipment, communications contractual services, rent.
Lead Poisoning outbreak response in Nigeria.  The GDD Operations Center deployed and funded 
CDC staff.
Legionella outbreak response in Mexico. The GDD Operations Center deployed and funded CDC 
staff.
Measles outbreak response in Malawi.  The GDD Operations Center deployed and funded CDC 
staff, transportation, supplies/equipment, communications contractual services, rent, utilities.
Meningitis outbreak response in Ghana. The GDD Operations Center deployed and funded CDC 
staff, transportation, supplies/equipment, contractual services.
Nodding Syndrome outbreak response in Uganda.  The GDD Operations Center deployed and 
funded CDC staff, transportation, supplies/equipment, communications.
Polio outbreak response in Democratic Republic of Congo.  The GDD Operations Center deployed 
and funded CDC staff.
Q Fever outbreak response in Netherlands.  The GDD Operations Center deployed and funded 
CDC staff, provision of lab supplies.
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Outbreak 
Response Country CDC Support
Aflatoxin Kenya Deployed and funded CDC staff, provision of lab supplies
Anthrax Scotland Deployed and funded CDC staff, provision of anti-toxin
Botulism Thailand Provided funding for the provision of anti-toxin and associated shipping costs
Cholera Haiti eployed and funded CDC staff, procurement and shipping 
Cholera Dominican  Republic Deployed and funded CDC staff  
Cholera Cameroon Deployed and funded CDC staff, transportation,  supplies/equipment, communications
Cholera Kenya Deployed and funded CDC staff, transportation,  supplies/equipment, communications
Earthquake 
Response Haiti Deployed and funded CDC staff, provision of lab supplies
Fungal  
Investigation Jamaica




Deployed and funded CDC staff, transportation, supplies/equipment,  
communications contractual services, rent
Lead  
Poisoning Niger a eploy d and funded CDC staff
Legionella Mexico Deployed and funded CDC staff
Measles Malawi Deployed and funded CDC staff, transportation, supplies/equipment,  communications contractual services, rent, utilities
Meningitis Ghana Deployed and funded CDC staff, transportation,  supplies/equipment, contractual services
Nodding 
Dis ase Uganda
Deployed and funded CDC staff, transportation, 
su plies/equipm nt, communicatio s 
Polio Democratic  Republic of Congo Deployed and funded CDC staff





Core Capacities of Global Disease Detection Regional Centers
Core Capacities of Global Disease Detection Regional Centers 
GDD Regional Centers are helping to strengthen public health systems and build 
essential infrastructure in host countries to uphold IHR 2005. The following core 
capacities were identified by internal and external GDD stakeholders as critical to the 
development of a country’s ability to rapidly identify and control emerging infectious 
diseases at the source:
Emerging infectious disease detection and response: Develop integrated disease 
surveillance, prevention, and control activities to rapidly identify and respond to a wide 
range of emerging infections (including respiratory syndromes, diarrheal diseases, food-
borne illnesses, zoonotic diseases, and others). 
Training in field epidemiology and laboratory methods: Provide training for scientists 
and public health practitioners in epidemiology and laboratory methods to build and 
strengthen public health systems and increase their capacity to detect and control 
emerging infectious diseases. 
Pandemic influenza preparedness and response: Develop laboratory and 
epidemiologic influenza surveillance capacity in host countries in order to improve and 
expand global surveillance networks, increase virus isolation and epidemiological data 
collection, and increase timely identification, reporting, and response to outbreaks. 
Zoonotic disease detection and response at the animal-human interface: Build 
veterinary expertise within the public health work force and develop enhanced 
partnerships between the Ministry of Agriculture and the Ministry of Health within host 
countries to strengthen capacity to detect and respond to zoonotic diseases. 
Emergency preparedness and risk communication: Improve host-country capacity to 
plan, exercise, and provide the necessary coordination, including delivery of timely and 
appropriate health messages, to achieve a state of readiness required to rapidly control 
and mitigate emerging infectious diseases and other public health emergencies.
Laboratory systems strengthening: Ensure appropriate containment facilities, 
equipment, policies/practices, security precautions, and occupational health programs 
to encourage working safely with highly pathogenic agents. Develop standardized test 
procedures, laboratory protocols, and management practices in order to strengthen 
laboratory operations.
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The threat of contagious disease transcends 
political boundaries, and the ability to prevent, 
quickly detect and contain outbreaks with 
pandemic potential has never been so important.
— The White House: 
“National Security Strategy.” 2010
For additional information, please contact
Frederick J. Angulo, DVM, PhD, Chief, Global Disease Detection Branch
Division of Global Disease Detection and Emergency Response
Center for Global Health, Centers for Disease Control and Prevention
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